2nd Circ. Won't Revive Antitrust Suit Over Cancer Drugs
A Second Circuit panel on Tuesday opted not to give a Russian pharmaceutical company another shot in a suit claiming Roche AG and its affiliates blocked the Russian firm from entering...To view the full article, register now.
Already a subscriber? Click here to view full article